The FDA statement on following the authorized dosing schedules for covid-19 vaccines
|The FDA says "two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing covid-19 infection in adults."
"Suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence."
''Available data continue to support the use of two specified doses of each authorized vaccine at specified intervals.''
For Pfizer-biotech vaccine, the interval is 21 days between 1st & 2nd dose; for Moderna covid-19 vaccine, the interval is 28 days between 1st & 2nd dose.
"What we have seen is that the data in the firms’ submissions regarding the first dose is commonly being misinterpreted."
Until vaccine makers have data supporting change, we continue to strongly recommend health care providers follow FDA authorised dosing schedule.''
Market implications
Wall Street Close: Stocks close lower on worries over Georgia elections and covid lockdown
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.